Scientists at NCCS have developed a novel platform for screening of potential anti-tumor agents, compounds and extracts, based on 3-dimensional Multi-Cellular Spheroids derived from tumor cells and prostate apoptosis response (PAR)-4 indicator that is linked to cell death. Continue reading
Available Technology & Capabilities
NCCS Meetings Calendar
Technology Categories
- Cancer Biology (6)
- Cell Biology (2)
- Computational Biology (3)
- Genetics (3)
- Immunology (5)
- Metabolic Diseases (3)
- Microbial Biology (4)
- Neuroscience (1)
- Stem Cells (12)
Products and Services
- Biopharma (18)
- Cell Therapy (6)
- Diagnostics (2)
- In-vitro Platform (8)
- Medical Device (3)
- Nutraceutical (2)
- Regenerative medicine (3)
- Umbilical Cord Blood Banking (3)
-
Related Links